Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer

BACKGROUND: Epidermal growth factor receptor (EGFR) is overexpressed in a subset of human epidermal growth factor receptor 2 (HER2)-positive breast cancers, and coexpression of HER2 and EGFR has been reported to be associated with poor clinical outcome. Moreover, interaction between HER2 and EGFR ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, H J, Seo, A N, Kim, E J, Jang, M H, Kim, Y J, Kim, J H, Kim, S-W, Ryu, H S, Park, I A, Im, S-A, Gong, G, Jung, K H, Kim, H J, Park, S Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453607/
https://www.ncbi.nlm.nih.gov/pubmed/25349977
http://dx.doi.org/10.1038/bjc.2014.556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453607/
https://www.ncbi.nlm.nih.gov/pubmed/25349977
http://dx.doi.org/10.1038/bjc.2014.556

Ejemplares similares